Brief: Diamyd Medical's Remygen® Trial Results Get Timeline Revision
April 20 (Reuters) - Diamyd Medical AB DMYDb.ST :
* MINOR TIMELINE REVISION FOR REMYGEN® TRIAL TOPLINE RESULTS
* TOPLINE RESULTS FROM UPPSALA UNIVERSITY HOSPITAL'S
REGENERATE-1
TRIAL ARE EXPECTED IN FIRST HALF OF MAY 2023
* REVISION REFLECTS A SMALL REVISION TO ACCOMMODATE
ADDITIONAL
TIME REQUIRED FOR COMPLETING STATISTICAL ANALYSES
Source text for Eikon: ID:nWkr3JLL6n
Further company coverage: DMYDb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))